Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments

Supportive Care in Cancer

Volumn 22, Issue 11, 2014, Pages 2941-2955

  Pullmer, Rachelle ^a   Linden, Wolfgang ^a,b   Rnic, Katerina ^c   Vodermaier, Andrea ^a,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Gastrointestinal neoplasms; Measures; Psychometrics; Reliability; Symptoms; Validity

Indexed keywords

ARTICLE; BOWEL FUNCTION QUESTIONNAIRE; CANCER INCIDENCE; CLINICAL PRACTICE; COLORECTAL CANCER; CONTENT VALIDITY; DYSFUNCTION AFTER UPPER GASTROINTESTINAL SURGERY; ESOPHAGO GASTRIC JUNCTION AND STOMACH MODULE; ESOPHAGUS CANCER; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER ESOPHAGUS; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GASTRIC CANCER MODULE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY COLORECTAL; FUNCTIONAL ASSESSMENT OF CANCER THERAPY COLORECTAL SYMPTOM INDEX; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEPATOBILIARY; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEPATOBILIARY SYMPTOM INDEX; GASTROINTESTINAL QUALITY OF LIFE INDEX; HUMAN; INTERNAL CONSISTENCY; LIVER CANCER; LIVER DISEASE QUALITY OF LIFE QUESTIONNAIRE; MEMORIAL SLOAN KETTERING CANCER CENTER BOWEL FUNCTION INSTRUMENT; MODIFIED FECAL INCONTINENCE QUALITY OF LIFE SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL COMPREHENSIVE CANCER NETWORK; PATIENT GENERATED INDEX; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE INSTRUMENT FIR CANCER PATIENTS COLORECTAL CANCER; STOMACH CANCER; SYMPTOM ASSESSMENT; SYSTEMATIC REVIEW; VALIDATION STUDY; GASTROINTESTINAL NEOPLASMS; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY;

GASTROINTESTINAL NEOPLASMS; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84919400094     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2250-z     Document Type: Article

References (54)

1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2013) Canadian Cancer Statistics. Canadian Cancer Society. http://www.cancer.ca/statistics
2. Cella D, Rosenbloom SK, Beaumont JL et al (2011) Development and validation of eleven symptom indexes to evaluate response to chemotherapy for advanced cancer. J Natl Compr Cancer Netw 9:269–278
3. Wang XS, Williams LA, Eng C et al (2010) Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116:2053–2063
4. Fan S, Eiser C, Ho MC (2010) Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol 8:550–564
5. Parameswaran R, Clifton, JC, Blazeby JM (2010) Quality of life measures in patients with esophageal cancer. In: Handbook of disease burdens and quality of life measures. Springer, New York, pp 2796–807
6. Mallet S, Deeks JJ, Halligan S et al (2006) Systematic reviews of diagnostic tests in cancer: reviews of methods and reporting. BMJ. doi:10.1136/bmj.38895.467130.55
7. Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN checklist assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 19:539–549
8. Mokkink LB, Terwee CB, Gibbons E et al (2010) Inter-rater agreement and reliability of the COSMIN (Consensus-based standards for the selection of health status measurement instruments) Checklist. BMC Med Res Methodol 10:82
9. Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use. Oxford University Press, New York
10. Cella D, Paul D, Yount S et al (2003) What are the most important symptom targets when treating advanced cancer? A survey of providers in the national comprehensive cancer network. Cancer Investig 21:526–535
11. Butt Z, Parikh ND, Beaumont JL et al (2012) Development and validation of a symptom index for advanced hepatobiliary and pancreatic cancers. Cancer. doi:10.1002/cncr.27588
12. Nakamura M, Kido Y, Yano M, Hosoya Y (2005) Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal carcinoma. Surg Today 35:535–542
13. Nakamura M, Kido Y, Egawa T (2008) Development of a 32-item scale to assess postoperative dysfunction after upper gastrointestinal cancer resection. J Clin Nurs 17:1440–1449
14. Nakamura M, Hosoya Y, Yano M et al (2011) Extent of gastric resection impacts patient quality of life: the Dysfunction After Upper Gastrointestinal Surgery for Cancer (DAUGS32) scoring system. Ann Surg Oncol 18:314–320
15. Nakamura M, Hosoya Y, Umeshita K et al (2011) Postoperative quality of life: development and validation of the “Dysfunction After Upper Gastrointestinal Surgery” scoring system. J Am Coll Surg 213:508–514
16. Blazeby JM, Alderson D, Winstone K et al (1996) Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 32A:1912–1917
17. Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394
18. Adelstein BA, Irwig L, Macaskill P et al (2008) A self administered reliable questionnaire to assess lower bowel symptoms. BMC Gastroenterol. doi:10.1186/1471-230X-8-8
19. Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255:922–928
20. Gujral S, Conroy T, Fleissner C et al (2007) Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 43:1564–1573
21. Whistance RN, Conroy T, Chie W et al (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45:3017–3026
22. Ward WL, Hahn EA, Mo F et al (1999) Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res 8:181–195
23. Temple LK, Bacik J, Savatta SG et al (2005) The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum 48:1353–1365
24. Hashimoto H, Shiokawa H, Funahashi K et al (2010) Development and validation of a modified fecal incontinence quality of life scale for Japanese patients after intersphincteric resection for very low rectal cancer. J Gastroenterol 45:928–935
25. Colwell HH, Mathias SD, Turner MP et al (2010) Psychometric evaluation of the FACT Colorectal Cancer Symptom Index (FCSI-9): reliability, validity, responsiveness, and clinical meaningfulness. Oncologist 15:308–316
26. Camilleri-Brennan J, Ruta DA, Steele RJ (2002) Patient generated index: new instrument for measuring quality of life in patients with rectal cancer. World J Surg 26:1354–1359
27. Yang Z, Lu YB, Wan CH et al (2008) Development of the system of quality of life instruments for cancer patients: colorectal cancer (QLICP-CR). Aizheng 27:96–100
28. Vickery CW, Blazeby JM, Conroy T et al (2001) Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer 37:966–971
29. Blazeby JM, Conroy T, Bottomley A et al (2004) Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO22, to assess quality of life in patients with gastric cancer. Eur J Cancer 40:2260–2268
30. Lagergren P, Fayers P, Conroy T et al (2007) Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer 43:2066–2073
31. Clifton JC, Finley RJ, Gelfand G et al (2007) Development and validation of a disease-specific quality of life questionnaire (EQOL) for potentially curable patients with carcinoma of the esophagus. Dis Esophagus 20:191–201
32. Darling G, Eton DT, Sulman J, Casson AG, Celia D (2006) Validation of the functional assessment of cancer therapy esophageal cancer subscale. Cancer 107:854–863
33. Eremenco SL, Cashy J, Webster K et al (2004) FACT-Gastric: a new international measure of QOL in gastric cancer. J Clin Oncol 22:8123
34. Garland SN, Pelletier G, Lawe A et al (2011) Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy–gastric (FACT-Ga) quality-of-life instrument. Cancer 117:1302–1312
35. Yeung SM, Shiu AT, Martin CR, Chu KM (2006) Translation and validation of the Chinese version of the Gastrointestinal Quality of Life Index in patients with gastric tumor. J Psychosom Res 61:469–477
36. Meng Q, Wan CH, Luo JH et al (2008) Development of the system of quality of life instruments for cancer patients: stomach cancer (QLICP-ST). Aizheng 27:1212–1216
37. Kavadas V, Blazeby JM, Conroy T et al (2003) Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer 39:1259–1263
38. Blazeby JM, Fayers P, Conroy T et al (2009) European Organization for Research Treatment of Cancer (EORTC) Quality of Life Group. Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases. Br J Surg 96:291–298
39. Blazeby JM, Currie E, Zee BC et al (2004) Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer 40:2439–2444
40. Chie WC, Blazeby JM, Hsiao CF et al (2012) International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18. Hepatology 55:1122–1129
41. Heffernan N, Cella D, Webster K et al (2002) Measuring health-related quality of life in patients with hepatobiliary cancers: the Functional Assessment of Cancer Therapy—Hepatobiliary questionnaire. J Clin Oncol 20:2229–2239
42. Steel JL, Eton DT, Cella D, Olek MC, Carr BI (2006) Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma. Ann Oncol 17:304–312
43. Casanovas T, Jane L, Herdman M et al (2010) Assessing outcomes in liver disease patients: reliability and validity of the Spanish version of the Liver Disease Quality of Life Questionnaire (LDQOL 1.0). Value Health 13:455–462
44. Yount S, Cella D, Webster K et al (2002) Assessment of patient-reported clinical outcome in pancreatic and other hepatobiliary cancer: the FACT Hepatobiliary Symptom Index. J Pain Symptom Manag 24:32–44
45. Wan C, Fang J, Yang Z et al (2010) Development and validation of a quality of life instrument for patients with liver cancer QOL-LC. Am J Clin Oncol 33:448–455
46. Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376
47. Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:570–579
48. Sprangers MA, te Velde A, Aaronson NK (1999) The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 35:238–247
49. Uwer L, Rotonda C, Guillemin F et al (2011) Responsiveness of EORTC QLQ-C30, QLQ- CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Out. doi:10.1186/1477-7525-9-70
50. Bassi C, Johnson C, Fitzsimmons D et al (1999) Quality of life assessment in pancreatic carcinoma: results of an European multicentric study. Chir Ital 51:359–366
51. Chisholm EM, De Dombal FT, Giles GR (1985) Validation of a self-administered questionnaire to elicit gastrointestinal symptoms. Br Med J 290:1795–1796
52. Davies A, Larsson G, Ardill J et al (2006) Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumours. Eur J Cancer 42:477–484
53. Friend E, Yadegarfar G, Byrne C et al (2011) Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21. Br J Cancer 104:587–592
54. Nieveen Van Dijkum EJ, Terwee CB et al (2000) Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma. Br J Surg 87:110–115